Literature DB >> 11978481

Oxidatively modified proteins in aging and disease.

M Flint Beal1.   

Abstract

There is a large body of evidence implicating oxidative damage in the pathogenesis of both normal aging and neurodegenerative diseases. Oxidative damage to proteins has been well established. Although there are a large number of potential oxidative modifications only a few have been systematically studied. The most frequently studied marker of oxidative damage to proteins is protein carbonyl groups. 3-Nitrotyrosine is thought to be a relatively specific marker of oxidative damage mediated by peroxynitrite. Increased concentrations of both protein carbonyls and 3-nitrotyrosine have been documented in both normal aging as well as in Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). These findings help to provide a rationale for trials of antioxidants in neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11978481     DOI: 10.1016/s0891-5849(02)00780-3

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  182 in total

1.  Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria.

Authors:  Han-Xiang Deng; Yong Shi; Yoshiaki Furukawa; Hong Zhai; Ronggen Fu; Erdong Liu; George H Gorrie; Mohammad S Khan; Wu-Yen Hung; Eileen H Bigio; Thomas Lukas; Mauro C Dal Canto; Thomas V O'Halloran; Teepu Siddique
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

2.  Elevated levels of protein carbonyls in sera of chronic fatigue syndrome patients.

Authors:  Iva V Smirnova; Martin L Pall
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

3.  The cyclooxygenase site, but not the peroxidase site of cyclooxygenase-2 is required for neurotoxicity in hypoxic and ischemic injury.

Authors:  Wenjin Li; Shasha Wu; Muzamil Ahmad; Jianfei Jiang; Hao Liu; Tetsuya Nagayama; Marie E Rose; Vladimir A Tyurin; Yulia Y Tyurina; Grigory G Borisenko; Natalia Belikova; Jun Chen; Valerian E Kagan; Steven H Graham
Journal:  J Neurochem       Date:  2010-03-17       Impact factor: 5.372

Review 4.  L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions.

Authors:  Andrzej Slominski; Michal A Zmijewski; John Pawelek
Journal:  Pigment Cell Melanoma Res       Date:  2011-09-02       Impact factor: 4.693

Review 5.  Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis.

Authors:  Lee J Martin
Journal:  IDrugs       Date:  2010-08

Review 6.  Targeting NOX enzymes in the central nervous system: therapeutic opportunities.

Authors:  Silvia Sorce; Karl-Heinz Krause; Vincent Jaquet
Journal:  Cell Mol Life Sci       Date:  2012-05-30       Impact factor: 9.261

7.  Identification of specific protein carbonylation sites in model oxidations of human serum albumin.

Authors:  Ani Temple; Ten-Yang Yen; Scott Gronert
Journal:  J Am Soc Mass Spectrom       Date:  2006-06-05       Impact factor: 3.109

8.  Superoxide-mediated formation of tyrosine hydroperoxides and methionine sulfoxide in peptides through radical addition and intramolecular oxygen transfer.

Authors:  Péter Nagy; Anthony J Kettle; Christine C Winterbourn
Journal:  J Biol Chem       Date:  2009-03-18       Impact factor: 5.157

9.  Multiple measures of functionality exhibit progressive decline in a parallel, stochastic fashion in Drosophila Sod2 null mutants.

Authors:  Nicole Piazza; Michael Hayes; Ian Martin; Atanu Duttaroy; Mike Grotewiel; Robert Wessells
Journal:  Biogerontology       Date:  2009-01-16       Impact factor: 4.277

10.  Theoretical and experimental studies of tyrosyl hydroperoxide formation in the presence of H-bond donors.

Authors:  Steven M Field; Frederick A Villamena
Journal:  Chem Res Toxicol       Date:  2008-09-25       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.